Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
Open Access
- 29 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101654
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01 CA258274)
- National Institute of General Medical Sciences (R01 GM132100)
- National Institutes of Health (P30 GM124169-01)
- U.S. Department of War (W81XWH-16-2-0030)
- National Heart Lung and Blood Institute (R01 HL157424)
- U.S. Department of Energy (DE-AC02-05CH11231, P20 GM103650)
This publication has 78 references indexed in Scilit:
- Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2Journal of Biological Chemistry, 2012
- Matrix Metalloproteinase 3 Is a Mediator of Pulmonary FibrosisThe American Journal of Pathology, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- MMPs as therapeutic targets—Still a viable option?Seminars in Cell & Developmental Biology, 2008
- Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injuryExperimental and Molecular Pathology, 2007
- The other side of MMPs: Protective roles in tumor progressionCancer and Metastasis Reviews, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004